This article was originally published on ETFTrends.com.
Biotech ETFs are movin’ on up on news that Pfizer is buying Array BioPharma for over $10 billion. SPDR S&P Biotech (XBI), iShares Nasdaq Biotechnology ETF (IBB), and ALPS Medical Breakthroughs ETF (SBIO) rose with the announcement of the acquisition. ETFs like XBI and IBB have fundamental differences. Depending on an investor’s strategy they can look to [...]
Continue Reading Below